Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Therapy of tuberculosis].

H Eule

    Zeitschrift Fur Die Gesamte Innere Medizin Und Ihre Grenzgebiete
    |March 1, 1979
    PubMed
    Summary

    Modern tuberculosis treatment uses effective antituberculotics, allowing cure in most cases. New drug combinations, including pyrazinamide, shorten treatment duration, improving patient outcomes and reducing costs.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Therapy of sarcoidosis].

    Zeitschrift fur Erkrankungen der Atmungsorgane·1988
    Same author

    The possible influence of corticosteroid therapy on the natural course of pulmonary sarcoidosis. Late results of a continuing clinical study.

    Annals of the New York Academy of Sciences·1986
    Same author

    [Daily ultrashort chemotherapy and intermittent short-term chemotherapy with 4 drugs of communicable pulmonary tuberculosis treated for the first time. Results of a cooperative multicenter study].

    Zeitschrift fur Erkrankungen der Atmungsorgane·1986
    Same author

    [The pharmacokinetics of rifampicin in the intermittent treatment of patients with pulmonary tuberculosis. 1. Excretion of rifampicin in the urine].

    Die Pharmazie·1985
    Same author

    [The pharmacokinetics of rifampicin in the intermittent treatment of patients with pulmonary tuberculosis. 2. The effect of rifampicin on the course of therapy for mycobacteriosis and non-tubercular infectious diseases].

    Die Pharmazie·1985
    Same author

    [Prognosis and indications of corticosteroid treatment of intrathoracic sarcoidosis--conclusions from a prospective study].

    Zeitschrift fur Erkrankungen der Atmungsorgane·1985

    Area of Science:

    • Medical Microbiology
    • Pharmacology

    Context:

    • Tuberculosis treatment has evolved significantly with advancements in antimicrobial agents.
    • Effective strategies for preventing drug resistance are crucial for sustained treatment success.

    Purpose:

    • To outline current, effective treatment regimens for tuberculosis.
    • To highlight the role of new antituberculotic agents and combinations in optimizing therapy.

    Summary:

    • Current tuberculosis therapy involves daily administration of three antituberculotics for 2-3 months, followed by intermittent therapy.
    • Key drugs include isoniazid (INH), rifampicin, streptomycin, and ethambutol, with treatment duration up to 12 months.
    • The incorporation of pyrazinamide is crucial for relapse prevention and enables treatment shortening to 9 months or less.

    Impact:

    • Shortened treatment durations improve patient adherence and reduce toxicity and healthcare costs.
    • Optimized therapeutic strategies enhance the overall management and curability of tuberculosis.
    • Advances in antituberculotic development are critical for combating resistant strains and improving global public health outcomes.

    Related Experiment Videos